Skip to Main Content

Paper Details

Evaluation of CRISPR/Cas9 exon-skipping vector for choroideremia using human induced pluripotent stem cell-derived RPE.
J Gene Med
1
2023
Author NameAffiliation
Bruce R ConklinGladstone Institutes
Bruce R ConklinOphthalmology and Cellular and Molecular Pharmacology University of California san francisco
  • 1 - 2

Datasets

Release 1.2